Cross-talk between Chk1 and Chk2 in double-mutant thymocytes

被引:49
作者
Zaugg, Kathrin
Su, Yu-Wen
Reilly, Patrick T.
Moolani, Yasmin
Cheung, Carol C.
Hakem, Razquallah
Hirao, Atsushi
Elledge, Stephen J.
Mak, Tak W.
机构
[1] Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2C1, Canada
[2] Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada
[3] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada
[4] Univ Hlth Network, Toronto, ON M5G 2C1, Canada
[5] Univ Toronto, Inst Med Sci, MARS Ctr, Toronto, ON M5G 2C1, Canada
[6] Ontario Canc Inst, Toronto, ON M5G 2C1, Canada
[7] Keio Univ, Sch Med, Sakaguchi Lab Dev Biol, Shinjuku, Tokyo 1608582, Japan
[8] Harvard Univ, Brigham & Womens Hosp, Ctr Genet & Genom, Howard Hughes Med Inst,Dept Genet, Boston, MA 02115 USA
关键词
apoptosis; cancer; T cells; p53; bcl2;
D O I
10.1073/pnas.0611584104
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Chk1 is a checkpoint kinase and an important regulator of mammalian cell division. Because null mutation of Chk1 in mice is embryonic lethal, we used the Cre-loxP system and the Lck promoter to generate conditional mutant mice in which Chk1 was deleted only in the T lineage. In the absence of Chk1, the transition of CD4(-)CD8(-) double-negative (DN) thymocytes to CD4(+)CD8(+) double-positive (DP) cells was blocked due to an increase in apoptosis at the DN2 and DN3 stages. Strikingly, loss of Chk1 activated the checkpoint kinase Chk2 as well as the tumor suppressor p53 in these thymocytes. However, the developmental defects caused by Chk1 deletion were not rescued by p53 inactivation. Significantly, even though Chk1 deletion is highly lethal in proliferating tissues, we succeeded in using in vivo methods to generate Chk1/Chk2 double-knockout T cells. Analysis of these T cells revealed an interesting interaction between Chk1 and Chk2 functions that partially rescued the apoptosis of the double-mutant cells. Thus, Chk1 is both critical for the survival of proliferating cells and engages in cross-talk with the Chk2 checkpoint kinase pathway. These factors have implications for the targeting of Chk1 as an anticancer therapy.
引用
收藏
页码:3805 / 3810
页数:6
相关论文
共 35 条
[1]   Chk1 and Chk2 kinases in checkpoint control and cancer [J].
Bartek, J ;
Lukas, J .
CANCER CELL, 2003, 3 (05) :421-429
[2]  
Bertoni F, 1999, GENE CHROMOSOME CANC, V26, P176, DOI 10.1002/(SICI)1098-2264(199910)26:2<176::AID-GCC11>3.0.CO
[3]  
2-3
[4]   Human Rad9 is required for the activation of S-phase checkpoint and the maintenance of chromosomal stability [J].
Dang, TY ;
Bao, SD ;
Wang, XF .
GENES TO CELLS, 2005, 10 (04) :287-295
[5]   Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent phosphorylation of Chk1 on Ser-317 in response to ionizing radiation [J].
Gatei, M ;
Sloper, K ;
Sörensen, C ;
Syljuäsen, R ;
Falck, J ;
Hobson, K ;
Savage, K ;
Lukas, J ;
Zhou, BB ;
Bartek, J ;
Khanna, KK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (17) :14806-14811
[6]   Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of Brca1 at distinct and overlapping sites -: In vivo assessment using phospho-specific antibodies [J].
Gatei, M ;
Zhou, BD ;
Hobson, K ;
Scott, S ;
Young, D ;
Khanna, KH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (20) :17276-17280
[7]   The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability [J].
Gudmundsdottir, K. ;
Ashworth, A. .
ONCOGENE, 2006, 25 (43) :5864-5874
[8]   The p53 pathway: positive and negative feedback loops [J].
Harris, SL ;
Levine, AJ .
ONCOGENE, 2005, 24 (17) :2899-2908
[9]   T-cell-specific deletion of a polypeptide N-acetylgalactosaminyltransferase gene by site-directed recombination [J].
Hennet, T ;
Hagen, FK ;
Tabak, LA ;
Marth, JD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (26) :12070-12074
[10]   Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner [J].
Hirao, A ;
Cheung, A ;
Duncan, G ;
Girard, PM ;
Elia, AJ ;
Wakeham, A ;
Okada, H ;
Sarkissian, T ;
Wong, JA ;
Sakai, T ;
de Stanchina, E ;
Bristow, RG ;
Suda, T ;
Lowe, SW ;
Jeggo, PA ;
Elledge, SJ ;
Mak, TW .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (18) :6521-6532